Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Prostatic Neoplasms × Metformin × Clear all

Phase

Phase 2 22 Phase 3 2 Phase 1 2 Phase NA 1 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Polycystic Ovary Syndrome 2 Pancreatic Neoplasms 2 Melanoma 2 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Prostate Cancer Recurrent 1 Infertility 1 Head and Neck Neoplasms 1 Glioma 1 Endometrial Neoplasms 1 Chondrosarcoma 1 Cholangiocarcinoma 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1

Interventions

Docetaxel 32 Prednisone 28 enzalutamide 19 Abiraterone Acetate 13 pembrolizumab 11 gallium 68 PSMA-11 9 Leuprolide 9 Radiotherapy 8 Pluvicto 8 Magnetic Resonance Spectroscopy 8 Nivolumab 7 Estramustine 7 abiraterone 6 Radiotherapy, Intensity-Modulated 6 Goserelin 6 Carboplatin 6 Biopsy 6 olaparib 5 cemiplimab 5 bicalutamide 5 Specimen Handling 5 Paclitaxel 5 Cyclophosphamide 5 temsirolimus 4 orteronel 4 darolutamide 4 cabazitaxel 4 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 4 Sirolimus 4 Radiosurgery 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04536805 2025-12-08

REPAIR

Institut Cancerologie de l'Ouest

Phase 1/2 Recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡